Logo
DCA

Smith & Nephew plc

eurostoxx600
SN.LHealthcareMedical Devices
1 091,50 £GB
-0.32%
Letzter Preis
1 091,50 £GB
2026-06-02
24h Änderung
-0.32%
-3.50 GBp
Volumen
1,8 Mio.
Gehandelte Anteile
Datenzuverlässigkeit
Hoch
9722 Punkte (38 Jahre)

Kursentwicklung

Starten Sie eine Simulation mit diesem Asset

SN.L

Globale Parameter

Verfügbare Daten von 1.7.1988 bis 2.6.2026

Fundamentalanalyse

New
CAGR (5y)
5.73%
Revenue Growth
Net Margin
10.14%
Profitability
ROE
11.82%
Return on Equity
Debt / EBITDA
2.17
Solvency
PEG Ratio
1.23
Valuation vs Growth
Rev. Growth (TTM)
7.40%
Current Trend
Technischer Fokus
SN.L
30d-Volatilität
25.82%
Abstand zur MA50
-6.96%
Abstand zur MA200
-14.05%
Abstand zum ATH
-45.15%
Momentum 3M
-20.42%
Risiko-Score
N/A

Moderate Volatilität. Momentum neutral.

Über Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

In diesen Wert investieren
Kaufen bei Saxo Bank
🏦Regulierter Broker
🌍Globaler Marktzugang
📈Profi-Tools

Werbelink. Kapital unterliegt Risiken.

Technische Analyse & Risiko

Schlüsselkennzahlen

CAGR4.96%
Volatilität25.82%
Max Drawdown-29.32%

Momentum : SN.L

Indicateur synthétique
PEURNEUTREAVIDITÉ
42
Fear

Risikoanalyse

VaR (95%)-2.28%
DCA Gesundheit
95/100

Jüngste Geschichte (60 Tage)

DatumSchlusskursVolumen
2026-06-021 091,50 £GB1.782.129
2026-06-011 095,00 £GB0
2026-05-291 111,00 £GB4.507.231
2026-05-280,00 £GB4.075.486
2026-05-271 126,50 £GB1.925.415
2026-05-261 133,50 £GB1.712.785
2026-05-221 138,00 £GB2.952.138
2026-05-211 142,50 £GB0
2026-05-201 145,00 £GB3.014.416
2026-05-191 157,00 £GB2.584.857
2026-05-181 122,00 £GB551
2026-05-151 112,00 £GB2.165.122
2026-05-141 104,00 £GB4.380.955
2026-05-131 102,50 £GB2.385.422
2026-05-121 103,00 £GB6.758.286
2026-05-111 073,50 £GB2.505.185
2026-05-081 093,00 £GB2.316.223
2026-05-071 114,00 £GB2.928.242
2026-05-061 117,50 £GB5.696.463
2026-05-051 159,00 £GB3.265.388
2026-05-011 147,00 £GB1.316.259
2026-04-301 137,00 £GB7.577.730
2026-04-291 132,50 £GB1.814.681
2026-04-281 157,50 £GB1.540.747
2026-04-271 182,00 £GB3.052.283
2026-04-241 158,00 £GB2.709.243
2026-04-231 184,50 £GB2.592.677
2026-04-221 214,50 £GB2.351.011
2026-04-211 221,00 £GB1.283.466
2026-04-201 262,50 £GB3.154.258
2026-04-171 268,00 £GB2.203.810
2026-04-161 252,00 £GB1.059.655
2026-04-151 262,50 £GB3.051.532
2026-04-141 263,00 £GB2.302.571
2026-04-131 242,00 £GB1.833.030
2026-04-101 246,50 £GB2.179.366
2026-04-091 227,50 £GB2.690.866
2026-04-081 226,50 £GB3.883.492
2026-04-071 193,00 £GB8.700.253
2026-04-021 207,50 £GB4.905.965
2026-04-011 199,50 £GB1.573.710
2026-03-311 185,00 £GB1.706.437
2026-03-301 200,50 £GB1.572.991
2026-03-271 193,00 £GB2.133.753
2026-03-261 195,50 £GB1.633.310
2026-03-251 209,50 £GB1.128.628
2026-03-241 205,00 £GB5.705.998
2026-03-231 187,50 £GB6.420.770
2026-03-201 200,50 £GB5.897.866
2026-03-191 205,50 £GB2.037.386
2026-03-181 251,50 £GB1.790.990
2026-03-171 251,50 £GB1.564.472
2026-03-161 241,50 £GB900.807
2026-03-131 248,00 £GB1.741.482
2026-03-121 240,50 £GB3.115.096
2026-03-111 243,50 £GB2.712.852
2026-03-101 232,00 £GB2.853.767
2026-03-091 252,00 £GB2.288.713
2026-03-061 284,50 £GB2.230.477
2026-03-051 306,00 £GB2.700.403

Jüngste Dividenden

DatumBetrag
2026-03-26+18,07 £GB
2025-10-02+11,26 £GB
2025-03-27+17,48 £GB
2024-10-03+11,10 £GB
2024-03-28+18,49 £GB
2023-10-05+11,89 £GB
2023-03-30+18,38 £GB
2022-09-29+12,91 £GB
2022-03-31+18,40 £GB
2021-09-30+10,50 £GB
2021-04-01+16,62 £GB
2020-10-01+11,07 £GB
2020-04-02+18,66 £GB
2019-10-03+11,50 £GB
2019-04-04+16,99 £GB
2018-10-04+10,67 £GB
2018-04-05+16,24 £GB
2017-10-05+9,34 £GB
2017-03-30+14,42 £GB
2016-10-06+10,08 £GB

Verwandte Assets